LEUVEN,
This organization will be comprised of Medical Strategy, Research & Development, Software Development, Medical Imaging Discovery, and Operations. It will be entirely dedicated to the development of Therapeutic Interventional Oncology solutions for patients with cancer. This team will be led by
"With this team of specialists, we want to provide excellence in developing Interventional Oncology solutions to improve the clinical benefit for patients with cancer, and thus contribute to society through healthcare", said
Terumo Interventional Systems is a leader in access technologies used in Interventional Oncology procedures and already offers a broad range of therapeutic solutions in EMEA. The Therapeutic Interventional Oncology portfolio comprises drug eluting microspheres with LifePearlTM microspheres, Selective Internal Radiation Therapy solutions with the Holmium platform (QuiremSpheresTM microspheres, QuiremScoutTM microspheres, QSuiteTM software) and Thermal Microwave ablation with TATO*.
The need for minimally invasive cancer treatments is growing to address the continuous rise of cancer in a global aging population.
"It is excellent news to see, within
With this organization in place, Terumo Interventional Systems will accelerate the commercial deployment of the Holmium platform (QuiremSpheresTM microspheres, QuiremScoutTM microspheres, QSuiteTM software) in EMEA. It will further extend the availability of the Holmium platform in other regions, in particular US as the largest radioembolization market but also
The creation of the Global Therapeutic Interventional Oncology organization will contribute to complete Terumo Interventional Systems' portfolio of solutions for the treatment of cancers in the liver and in other organs. In particular, it currently investigates the development of radiation oncology technologies for the treatment of pancreatic tumors. It will also innovate in new targeted drug delivery solutions.
* LifePearlTM microspheres is CE marked and available in QuiremSpheresTM microspheres, QuiremScoutTM microspheres, QSuiteTM software are CE marked and available in TATO is CE marked and available in |
About
View original content to download multimedia:http://www.prnewswire.com/news-releases/terumo-is-building-a-global-therapeutic-interventional-oncology-team-to-offer-more-therapeutic-solution-to-cancer-patients-301266777.html
SOURCE
© Canada Newswire, source